CGMS Market Overview
Continuous Glucose Monitoring System (CGM) Market is expected to register CAGR of over 13% during forecast period. As per the WHO data, about half of all the mortality can be related with the high blood glucose levels, that occur before age of 70 years. The organization also supposes diabetes to be seventh-leading cause of the mortality by 2030. For patients dependent on insulin pumps or on the daily injections, CGMS founds itself to be helpful tool, that helps in development of glycemic balance deprived of growing danger of the fatal hypoglycemia. As studied in numerous clinical trials, the diabetic patients with the Type 1 diabetes mellitus (T1DM) using incessant glucose monitoring have revealed to have the better glycemic control, in contrast to when the glucometer is used for the routine self-monitoring blood glucose.
Trend follows in children, as well as for those who use CGMS on regular basis. The results in the children show better HbA1c levels without an augmented frequency of the hypoglycemia. The present CGMS models permit administer glucose oxidase built electrochemical subcutaneous sensors for discovery of glucose levels in interstitial fluid. The CGM devices can retrospectively display trends in levels of blood glucose by transferring the data or give real-time picture of the glucose levels through the receiver displays. Most of real-time CGMs can offer alert to patients, caregivers or parents during actual or incomplete glycemic visits, to ease timely management of the blood glucose.
CGMS Market Segment Overview
The CGMS are used to provide further descriptive depiction of the blood glucose patterns and the tendencies than what they can achieve by conservative routine checking of the glucose levels at set intervals. Current CGMS devices can either display the trends in levels of blood glucose by transferring the data or give real-time picture of the glucose levels through the receiver displays. This factor, along with fact that CGMS devices are becoming less expensive with advent of new technologies, such as cell phone incorporation, is likely to propel the steady growth of CGMS market during forecast period.
CGMS Regional Overview
In the North America, the U.S. accounted for over 90% of the market value in the year 2020. By 2026, continuous glucose monitoring market in the country is anticipated to be valued over USD 4.5 billion. Continuous Glucose Monitoring Market in U.S. is expected to register CAGR of over 10% during forecast period. It is imperious that CGMS devices be used together with insulin pumps. As trends show higher number of diabetic patients making use of insulin pumps for the diabetes management, it can be foreseen that number of units of the CGMS devices sold will also trail.
Abbott and the Dexcom received FDA consent to the use of Continuous Glucose Monitoring System in U.S. hospitals for THE Coronavirus-affected people. The Dexcom began delivering CGMs to the hospitals in last April 2020 and plans to make over 100,000 sensors to sell to the hospitals at low-cost and also, planned to donate over 10,000 phones and CGMS readers to these hospitals for scanning sensors.
CGMS Market Competitor overview
A major share of market is held by the CGMS manufacturers that are associated with the strategy-based M&A processes and are continually entering new markets to produce new income streams and to improvement in the existing ones. These actions taken by market players will ensure competitive marketplace, so, forcing companies to experiment with even more new technologies, to safeguard uniqueness in the products. Similarly, one of implications of competition in market is that it will confirm constant decrease in average selling price of CGMS units produced. The market is combined with some players accounting for major share. Companies are collaborating to surge their technological know-how and also to fasten product development cycle.
CGMS Market, Key Players
CGMS Market Segmentation
CGMS Market, By Product Components
CGMS Market, By Product Demographics
CGMS Market, By End User
CGMS market, By Region:
Continuous Glucose Monitoring System (CGM) Market is expected to register CAGR of over 13% during forecast period. As per the WHO data, about half of all the mortality can be related with the high blood glucose levels, that occur before age of 70 years. The organization also supposes diabetes to be seventh-leading cause of the mortality by 2030. For patients dependent on insulin pumps or on the daily injections, CGMS founds itself to be helpful tool, that helps in development of glycemic balance deprived of growing danger of the fatal hypoglycemia. As studied in numerous clinical trials, the diabetic patients with the Type 1 diabetes mellitus (T1DM) using incessant glucose monitoring have revealed to have the better glycemic control, in contrast to when the glucometer is used for the routine self-monitoring blood glucose.
Trend follows in children, as well as for those who use CGMS on regular basis. The results in the children show better HbA1c levels without an augmented frequency of the hypoglycemia. The present CGMS models permit administer glucose oxidase built electrochemical subcutaneous sensors for discovery of glucose levels in interstitial fluid. The CGM devices can retrospectively display trends in levels of blood glucose by transferring the data or give real-time picture of the glucose levels through the receiver displays. Most of real-time CGMs can offer alert to patients, caregivers or parents during actual or incomplete glycemic visits, to ease timely management of the blood glucose.
CGMS Market Segment Overview
The CGMS are used to provide further descriptive depiction of the blood glucose patterns and the tendencies than what they can achieve by conservative routine checking of the glucose levels at set intervals. Current CGMS devices can either display the trends in levels of blood glucose by transferring the data or give real-time picture of the glucose levels through the receiver displays. This factor, along with fact that CGMS devices are becoming less expensive with advent of new technologies, such as cell phone incorporation, is likely to propel the steady growth of CGMS market during forecast period.
CGMS Regional Overview
In the North America, the U.S. accounted for over 90% of the market value in the year 2020. By 2026, continuous glucose monitoring market in the country is anticipated to be valued over USD 4.5 billion. Continuous Glucose Monitoring Market in U.S. is expected to register CAGR of over 10% during forecast period. It is imperious that CGMS devices be used together with insulin pumps. As trends show higher number of diabetic patients making use of insulin pumps for the diabetes management, it can be foreseen that number of units of the CGMS devices sold will also trail.
Abbott and the Dexcom received FDA consent to the use of Continuous Glucose Monitoring System in U.S. hospitals for THE Coronavirus-affected people. The Dexcom began delivering CGMs to the hospitals in last April 2020 and plans to make over 100,000 sensors to sell to the hospitals at low-cost and also, planned to donate over 10,000 phones and CGMS readers to these hospitals for scanning sensors.
CGMS Market Competitor overview
A major share of market is held by the CGMS manufacturers that are associated with the strategy-based M&A processes and are continually entering new markets to produce new income streams and to improvement in the existing ones. These actions taken by market players will ensure competitive marketplace, so, forcing companies to experiment with even more new technologies, to safeguard uniqueness in the products. Similarly, one of implications of competition in market is that it will confirm constant decrease in average selling price of CGMS units produced. The market is combined with some players accounting for major share. Companies are collaborating to surge their technological know-how and also to fasten product development cycle.
CGMS Market, Key Players
• Abbott Laboratories
• Dexcom, Inc.
• A. Menarini Diagnostics
• Echo Therapeutics, Inc.
• GlySens Incorporated
• Johnson & Johnson
• Medtronic plc
• Senseonics Holdings, Inc.
• F. Hoffmann-La Roche Ltd
CGMS Market Segmentation
CGMS Market, By Product Components
• Sensors
• Transmitters & Receivers
• Integrated Insulin Pumps
CGMS Market, By Product Demographics
• Child Population (<=14years)
• Adult Population (>14years)
CGMS Market, By End User
• Clinics and Diagnostics Centers
• ICUs
• Home Healthcare
CGMS market, By Region:
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
CGMS Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global CGMS Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Segment 1
- 5.2.1. Sub-Segment 1
- 5.2.2. Sub-Segment 2
- 5.3. Market Analysis, Insights and Forecast – By Segment 2
- 5.3.1. Sub-Segment 1
- 5.3.2. Sub-Segment 2
- 5.3.3. Sub-Segment 3
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Segment 3
- 5.4.1. Sub-Segment 1
- 5.4.2. Sub-Segment 2
- 5.4.3. Sub-Segment 3
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America CGMS Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Segment 1
- 6.2.1. Sub-Segment 1
- 6.2.2. Sub-Segment 2
- 6.3. Market Analysis, Insights and Forecast – By Segment 2
- 6.3.1. Sub-Segment 1
- 6.3.2. Sub-Segment 2
- 6.3.3. Sub-Segment 3
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Segment 3
- 6.4.1. Sub-Segment 1
- 6.4.2. Sub-Segment 2
- 6.4.3. Sub-Segment 3
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America CGMS Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Segment 1
- 7.2.1. Sub-Segment 1
- 7.2.2. Sub-Segment 2
- 7.3. Market Analysis, Insights and Forecast – By Segment 2
- 7.3.1. Sub-Segment 1
- 7.3.2. Sub-Segment 2
- 7.3.3. Sub-Segment 3
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Segment 3
- 7.4.1. Sub-Segment 1
- 7.4.2. Sub-Segment 2
- 7.4.3. Sub-Segment 3
- 7.4.4. Others
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe CGMS Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Segment 1
- 8.2.1. Sub-Segment 1
- 8.2.2. Sub-Segment 2
- 8.3. Market Analysis, Insights and Forecast – By Segment 2
- 8.3.1. Sub-Segment 1
- 8.3.2. Sub-Segment 2
- 8.3.3. Sub-Segment 3
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Segment 3
- 8.4.1. Sub-Segment 1
- 8.4.2. Sub-Segment 2
- 8.4.3. Sub-Segment 3
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific CGMS Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Segment 1
- 9.2.1. Sub-Segment 1
- 9.2.2. Sub-Segment 2
- 9.3. Market Analysis, Insights and Forecast – By Segment 2
- 9.3.1. Sub-Segment 1
- 9.3.2. Sub-Segment 2
- 9.3.3. Sub-Segment 3
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Segment 3
- 9.4.1. Sub-Segment 1
- 9.4.2. Sub-Segment 2
- 9.4.3. Sub-Segment 3
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa CGMS Market Analysis (USD Billion), Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Segment 1
- 10.2.1. Sub-Segment 1
- 10.2.2. Sub-Segment 2
- 10.3. Market Analysis, Insights and Forecast – By Segment 2
- 10.3.1. Sub-Segment 1
- 10.3.2. Sub-Segment 2
- 10.3.3. Sub-Segment 3
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast – By Segment 3
- 10.4.1. Sub-Segment 1
- 10.4.2. Sub-Segment 2
- 10.4.3. Sub-Segment 3
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.3.1. Company 1
- 11.3.1.1. Business Overview
- 11.3.1.2. Segment 1 & Service Offering
- 11.3.1.3. Overall Revenue
- 11.3.1.4. Geographic Presence
- 11.3.1.5. Recent Development
- 11.3.2. Company 2
- 11.3.3. Company 3
- 11.3.4. Company 4
- 11.3.5. Company 5
- 11.3.6. Company 6
- 11.3.7. Company 7
- 11.3.8. Company 8
- 11.3.9. Company 9
- 11.3.10. Company 10
- 11.3.11. Company 11
- 11.3.12. Company 12
- 11.3.1. Company 1